Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Osteosarcoma × Losartan × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Squamous Cell Carcinoma of Head and Neck 1 Radiation Fibrosis Syndrome 1 Pancreatic Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Osteosarcoma 1 Inflammation 1 Fibrosis 1 Camurati-Engelmann Syndrome 1 Breast Neoplasms 1

Interventions

fludarabine 5 Cyclophosphamide 5 cabozantinib 4 Temozolomide 4 Doxorubicin 4 Zoledronic Acid 3 Methotrexate 3 Gemcitabine 3 Cisplatin 3 irinotecan sucrosofate 2 atezolizumab 2 X-Rays 2 Vincristine 2 Sunitinib 2 Specimen Handling 2 Radiosurgery 2 Phantoms, Imaging 2 Magnetic Resonance Spectroscopy 2 Irinotecan 2 Ifosfamide 2 Disulfiram 2 Biopsy 2 vactosertib 1 trametinib 1 talazoparib 1 surufatinib 1 silmitasertib 1 selinexor 1 regorafenib 1 penpulimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03900793 2026-02-03

Losartan + Sunitinib in Treatment of Osteosarcoma

University of Colorado, Denver

Phase 1 Recruiting

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡